emerginggrowth.com
Regen BioPharma, Inc. (OTC Pink: RGBP) up 100% after Filing Patent Application on Synergy of Cannabidiol With NR2F6 Modulation - EmergingGrowth.com
Miami, FL – August 7, 2019 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Regen BioPharma, Inc.(OTC Pink: RGBP). Regen BioPharma, Inc. focuses on the development of small molecule therapies for treating cancer and autoimmune disorders in the United States. …